MedTrace Logo

Swedish Oesophago-Gastric Study

NCT05540119 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2022-09-19

No results posted yet for this study

Summary

The overarching aim of this nationwide Swedish cohort study is to reduce death and suffering from oesophageal and gastric tumours. This aim can be accomplished by a broad research approach that aims to identify:

1. Risk factors and preventive actions
2. Early detection
3. Improved treatment

Conditions

  • Oesophageal Cancer
  • Gastric Cancer
  • Surgical Treatment
  • Aetiology
  • Prognostic Factors
  • Survival
  • Prediction
  • Treatment

Interventions

PROCEDURE

Surgery

Patients who undergo surgery are separately assessed

Sponsors & Collaborators

  • Johannes Asplund

    collaborator UNKNOWN

  • Fredrik Mattsson

    collaborator UNKNOWN

  • Eivind Gottlieb

    collaborator UNKNOWN

  • Wilhelm Leijonmarck

    collaborator UNKNOWN

  • Ivan Ernudd

    collaborator UNKNOWN

  • Ellinor Lundberg

    collaborator UNKNOWN

  • Sheraz Markar

    collaborator UNKNOWN

  • Giola Santoni

    collaborator UNKNOWN

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Jesper Lagergren, MD PhD · Karolinska Institutet

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2020-09-01
Completion
2023-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540119 on ClinicalTrials.gov